Clinical Trial Update: Efficacy of Intravesical Oxybutynin in Children With Neurogenic Bladder Dysfunction [Phase 3]

View source ↗

Summary

Phase 3 study evaluating intravesical oxybutynin for neurogenic bladder dysfunction in children with spina bifida; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Bladder Dysfunction
• Spina Bifida

Drugs mentioned

• oxybutynin (oxybutynin)

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Spina Bifida | Phase 3 | Status: RECRUITING